Discover 2,017 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Michigan offers access to numerous clinical research opportunities for both healthy volunteers interested in paid studies and those with specific health conditions. Research hubs in Detroit, Grand Rapids, and Ann Arbor are enrolling participants, providing access to innovative treatments and personalized care options.
Filter
1
Filter results
Results: 2,017
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Boston MA, Worcester MA, Stony Brook NY, Manhasset NY,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase 3, Recruiting
Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Ann Arbor MI
Sponsor: University of Michigan Rogel Cancer Center
Sex: Female
Age: 18+
Code: NCT07158021
Phase 2, Recruiting
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
for
Atrial Fibrillation
Location: Lake Success NY, The Bronx NY, Winchester VA, Miami FL,
Sponsor: Biosense Webster, Inc.
Sex: All
Age: 22+
Code: NCT07227532
Recruiting
Impact of Intraoperative Oxygenation Practices on Patient Outcomes
for
Surgeries Undergoing General Anesthesia
Location: Ann Arbor MI, Nashville TN, Omaha NE, Salt Lake City UT
Sponsor: Frederic T Billings IV
Sex: All
Age: 18+
Code: NCT07224243
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
for
Cutaneous Lupus Erythematosus (CLE),
Location: Fairport NY, Miami FL, DeBary FL, Tampa FL,
Sponsor: Ventus Therapeutics U.S., Inc.
Sex: All
Age: 18 - 70+
Code: NCT07260877
Phase 2, Recruiting
Reducing Lead Dust Exposure in Older Housing
for
Exposure to Toxic Dust, Elevated Blood Lead Levels
Location: East Lansing MI
Sponsor: Michigan State University
Sex: All
Age: 0 - 7
Code: NCT07485608
Recruiting
A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
for
Secondary Progressive Multiple Sclerosis
Location: Worcester MA, New York NY, Boca Raton FL, Maitland FL,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07299019
Phase 3, Recruiting
Clinical Study to Evaluate the Safety and Effectiveness of Arcevo LSA
for
Aortic Arch Aneurysm, Aortic Arch Dissection,
Location: The Bronx NY, New York NY, Philadelphia PA,
Sponsor: Artivion Inc.
Sex: All
Age: 18 - 70+
Code: NCT07089576
Recruiting
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
for
Platinum-resistant Ovarian Cancer
Location: Boston MA, New Haven CT, Fairfax VA, Sarasota FL,
Sponsor: Stemline Therapeutics, Inc.
Sex: Female
Age: 18+
Code: NCT07226427
Phase 1, Recruiting
A Study to Evaluate the Efficacy, Safety, and PK of AZD0292 Administered IV in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
for
Bronchiectasis With Pseudomonas Aeruginosa Colonization
Location: Quebec, New York NY, Saint-Charles-Borromee,
Sponsor: AstraZeneca
Sex: All
Age: 12+
Code: NCT07088926
Phase 2, Recruiting
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Willow Grove PA, Richmond VA, Fairfax VA, Rochester NY,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06769698
Phase 2, Recruiting
Metformin Combined With Chemotherapy and/or Immunotherapy in Solid Malignancies
for
Advanced Solid Tumor
Location: Port Huron MI, Macomb MI, Detroit MI, Lapeer MI,
Sponsor: Barbara Ann Karmanos Cancer Institute
Sex: All
Age: 18+
Code: NCT07098299
Phase 1, Recruiting
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
for
Locally Advanced Urothelial Carcinoma,
Location: Worcester MA, Saint Johnsbury VT, Lebanon NH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06524544
Phase 3, Recruiting
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
for
Systemic Lupus Erythematosus (SLE)
Location: Calgary, West Long Branch NJ, Brooklyn NY, Ottawa,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 16+
Code: NCT07175285
Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, Houston NC, St. Petersburg FL, Ann Arbor MI,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06906627
Recruiting
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
for
Heart Failure - NYHA II - IV
Location: Fall River MA, Flushing NY, New York NY, Albany NY,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT07069738
Recruiting
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
for
Chronic Kidney Disease(CKD), Type 2 DM,
Location: Durham NC, St. Petersburg FL, Ann Arbor MI,
Sponsor: Duke University
Sex: All
Age: 18+
Code: NCT06906640
Recruiting
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Location: Foxborough MA, The Bronx NY, Yardley PA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07783802
Phase 2, Recruiting
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma